A review of innate and adaptive immunity to coccidioidomycosis.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
01 Feb 2019
Historique:
received: 06 09 2018
accepted: 28 11 2018
entrez: 29 1 2019
pubmed: 29 1 2019
medline: 4 4 2019
Statut: ppublish

Résumé

Coccidioidomycosis is a human fungal disease cause by inhalation of aerosol spores produced by Coccidioides posadasii or Coccidioides immitis. This disease is a common cause of community-acquired pneumonia in the endemic areas of the Southwestern United States. It also can present as a life-threatening disease as the fungal cells disseminate to skin, bone, and central nervous system. The outcome of coccidioidomycosis is largely determined by the nature of host immune response to the infection. Escalation of symptomatic infections and increased cost of long-term antifungal treatment warrant a concerted effort to better understand the innate and adaptive immune responses and the genetics associated with coccidioidomycosis susceptibility. This knowledge can be harnessed for development of a human vaccine against Coccidioides and advance clinic management of this disease. This review discusses recently reported studies on innate and adaptive immunity to Coccidioides infection, Mendelian susceptibility to disseminated disease and progress toward a human vaccine against this formidable disease.

Identifiants

pubmed: 30690602
pii: 5300144
doi: 10.1093/mmy/myy146
pmc: PMC6347076
doi:

Substances chimiques

Antifungal Agents 0
Fungal Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S85-S92

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI135005
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI114762
Pays : United States

Références

Infect Immun. 1999 Jun;67(6):2916-9
pubmed: 10338499
Infect Immun. 1999 Jun;67(6):2935-40
pubmed: 10338502
Infect Immun. 2001 May;69(5):2878-87
pubmed: 11292702
Infect Immun. 2003 Jun;71(6):3010-9
pubmed: 12761077
Med Mycol. 2004 Jun;42(3):189-216
pubmed: 15283234
Clin Microbiol Rev. 2004 Oct;17(4):804-39, table of contents
pubmed: 15489350
Infect Immun. 2005 Mar;73(3):1553-60
pubmed: 15731053
Vaccine. 2005 May 20;23(27):3535-44
pubmed: 15855012
Infect Immun. 2006 Mar;74(3):1865-72
pubmed: 16495561
J Infect Dis. 2006 May 1;193(9):1323-31
pubmed: 16586371
J Immunol. 2006 May 1;176(9):5513-8
pubmed: 16622020
Infect Immun. 2006 Jun;74(6):3387-95
pubmed: 16714569
Vaccine. 2006 Jul 26;24(31-32):5904-11
pubmed: 16759762
Infect Immun. 2006 Oct;74(10):5802-13
pubmed: 16988258
Nat Immunol. 2007 Jun;8(6):630-8
pubmed: 17450144
J Toxicol Environ Health A. 2007 Jul;70(13):1116-24
pubmed: 17558806
Infect Immun. 2007 Dec;75(12):5777-87
pubmed: 17875631
J Immunol. 2007 Dec 1;179(11):7791-9
pubmed: 18025225
Nature. 2008 Apr 10;452(7188):773-6
pubmed: 18337720
Semin Respir Crit Care Med. 2008 Apr;29(2):166-73
pubmed: 18365998
Genes Immun. 2008 Jun;9(4):338-48
pubmed: 18418396
J Exp Clin Cancer Res. 2008 Sep 19;27:40
pubmed: 18803849
Infect Immun. 2008 Dec;76(12):5553-64
pubmed: 18852250
Pediatr Infect Dis J. 2009 Jul;28(7):664-6
pubmed: 19483664
Infect Immun. 2009 Aug;77(8):3196-208
pubmed: 19487479
Clin Infect Dis. 2009 Sep 15;49(6):e62-5
pubmed: 19681704
Med Mycol. 2010 May;48(3):470-5
pubmed: 20370361
Clin Infect Dis. 2011 Feb 15;52(4):e99-e102
pubmed: 21258095
Nat Rev Immunol. 2011 Apr;11(4):275-88
pubmed: 21394104
Eur J Immunol. 2011 Aug;41(8):2260-8
pubmed: 21681738
J Immunol. 2011 Aug 1;187(3):1421-31
pubmed: 21705621
J Exp Med. 2011 Aug 1;208(8):1635-48
pubmed: 21727188
Infect Immun. 2011 Nov;79(11):4511-22
pubmed: 21859851
Nat Immunol. 2012 Jan 22;13(3):246-54
pubmed: 22267217
Vaccine. 2012 Jun 29;30(31):4681-90
pubmed: 22575167
J Immunol. 2012 Jul 1;189(1):312-7
pubmed: 22649195
Nat Immunol. 2012 Sep;13(9):817-22
pubmed: 22910394
Emerg Infect Dis. 2012 Sep;18(9):1476-9
pubmed: 22931562
Infect Immun. 2012 Nov;80(11):3960-74
pubmed: 22949556
MBio. 2013 Feb 05;4(1):e00597-12
pubmed: 23386437
J Allergy Clin Immunol. 2013 Jun;131(6):1624-34
pubmed: 23541320
Curr Fungal Infect Rep. 2012 Dec 1;6(4):235-244
pubmed: 23585916
Front Immunol. 2013 Jul 31;4:214
pubmed: 23914187
Clin Vaccine Immunol. 2013 Oct;20(10):1585-91
pubmed: 23945157
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
PLoS Pathog. 2013;9(12):e1003768
pubmed: 24367252
Infect Immun. 2014 Mar;82(3):1147-56
pubmed: 24379281
J Immunol. 2014 Feb 1;192(3):1107-1119
pubmed: 24391211
Infect Immun. 2014 Feb;82(2):903-13
pubmed: 24478103
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Infect Immun. 2014 May;82(5):2106-14
pubmed: 24614655
Front Immunol. 2014 Sep 23;5:459
pubmed: 25295041
Infect Immun. 2016 Mar 24;84(4):1166-75
pubmed: 26857574
BMC Genomics. 2016 Jun 23;17 Suppl 2:444
pubmed: 27357693
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Vaccine. 2016 Oct 17;34(44):5336-5343
pubmed: 27622300
Emerg Infect Dis. 2017 Feb;23(2):
pubmed: 28098554
Microorganisms. 2017 Mar 16;5(1):
pubmed: 28300772
Methods Mol Biol. 2017;1625:45-64
pubmed: 28584982
Trends Pharmacol Sci. 2017 Sep;38(9):771-793
pubmed: 28668223
J Fungi (Basel). 2016 Dec 16;2(4):null
pubmed: 29376949
Infect Immun. 2018 Apr 2;:
pubmed: 29610256
Infect Immun. 2018 Aug 13;:
pubmed: 30104216
Infect Immun. 1988 Jan;56(1):13-7
pubmed: 3335400
Infect Immun. 1983 Jun;40(3):912-6
pubmed: 6852925
J Exp Med. 1996 Jun 1;183(6):2635-44
pubmed: 8676084
Infect Immun. 1996 Sep;64(9):3609-13
pubmed: 8751906
Transplantation. 1997 Oct 15;64(7):1017-27
pubmed: 9381524
Infect Immun. 1998 Aug;66(8):3519-22
pubmed: 9673228
Infect Immun. 1998 Sep;66(9):4397-402
pubmed: 9712793
J Immunol. 1998 Oct 1;161(7):3400-7
pubmed: 9759857

Auteurs

Chiung-Yu Hung (CY)

Department of Biology and South Texas Center for Emerging Infectious Diseases, University of Texas, San Antonio, Texas, USA.

Amy P Hsu (AP)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Steven M Holland (SM)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Joshua Fierer (J)

Infectious Diseases Section, VA Healthcare San Diego, California, USA.
Department of Medicine, Division of Infectious Diseases, University of California San Diego School of Medicine, San Diego, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH